Search Results - "Vermeer, Patricia"

Refine Results
  1. 1

    Coverage of the 2011 Q fever vaccination campaign in the Netherlands, using retrospective population-based prevalence estimation of cardiovascular risk-conditions for chronic Q fever by Vermeer-de Bondt, Patricia E, Schoffelen, Teske, Vanrolleghem, Ann M, Isken, Leslie D, van Deuren, Marcel, Sturkenboom, Miriam C J M, Timen, Aura

    Published in PloS one (24-04-2015)
    “…In 2011, a unique Q fever vaccination campaign targeted people at risk for chronic Q fever in the southeast of the Netherlands. General practitioners referred…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Etiologies for seizures around the time of vaccination by Verbeek, Nienke E, Jansen, Floor E, Vermeer-de Bondt, Patricia E, de Kovel, Carolien G, van Kempen, Marjan J A, Lindhout, Dick, Knoers, Nine V A M, van der Maas, Nicoline A T, Brilstra, Eva H

    Published in Pediatrics (Evanston) (01-10-2014)
    “…This study was an assessment of the incidence, course, and etiology of epilepsy with vaccination-related seizure onset in a population-based cohort of…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    THE EFFECT OF AGE AND DOSE NUMBER ON THE RISK OF COLLAPSE (HYPOTONIC-HYPORESPONSIVE EPISODE) AFTER PERTUSSIS VACCINATION by Vermeer-de Bondt, Patricia E, van der Maas, Nicoline A. T

    Published in The Pediatric infectious disease journal (01-04-2008)
    “…The Netherlands vaccination schedule has been advanced by 1 month. The reporting rate of collapse or hypotonic-hyporesponsive episode increased from 5.2 [95%…”
    Get full text
    Journal Article
  8. 8

    Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: follow up study by Bondt, Patricia E Vermeer-de, Labadie, Jerry, Rümke, Hans C

    Published in BMJ (21-03-1998)
    “…3 4 The only follow up study, which assessed a small series, was inconclusive about sequelae. 5 Comparing the rates of collapse between countries poses…”
    Get full text
    Journal Article
  9. 9

    Two doses of pandemic influenza A(H1N1) vaccine: Tolerability in healthy young children in the Netherlands by Klooster, Tessa M. van 't, Kemmeren, Jeanet M., de Melker, Hester E., Vermeer-de Bondt, Patricia E., van der Maas, Nicoline A.T.

    Published in Human vaccines (01-10-2011)
    “…During the 2009 influenza pandemic, children aged 6 months up to and including 4 years, without chronic illness, were vaccinated with two doses of Pandemrix®…”
    Get full text
    Journal Article
  10. 10

    Adverse events and association with age, sex and immunological parameters of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011 by Schoffelen, Teske, Wong, Albert, Rümke, Hans C, Netea, Mihai G, Timen, Aura, van Deuren, Marcel, Vermeer-de Bondt, Patricia E

    Published in Vaccine (20-11-2014)
    “…Highlights • Q fever vaccination was safe, although rather reactogenic in this old-age risk-group. • Prior skin-testing led to local adverse events (AE) in 41%…”
    Get full text
    Journal Article
  11. 11

    Implementation of a Q fever vaccination program for high-risk patients in the Netherlands by Isken, Leslie D, Kraaij-Dirkzwager, Marleen, Vermeer-de Bondt, Patricia E, Rümke, Hans C, Wijkmans, Clementine, Opstelten, Wim, Timen, Aura

    Published in Vaccine (28-05-2013)
    “…Highlights • 1368 patients at high risk for Q fever vaccination were vaccinated. • The Q fever vaccine was rather reactogenic but safe in these high-risk…”
    Get full text
    Journal Article
  12. 12

    Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs by Kimman, Tjeerd G., Boot, Hein J., Berbers, Guy A.M., Vermeer-de Bondt, Patricia E., Ardine de Wit, G., de Melker, Hester E.

    Published in Vaccine (29-05-2006)
    “…Among all public health provisions national immunization programs (NIPs) are beyond doubt one of the most effective in reducing mortality, morbidity, and costs…”
    Get full text
    Journal Article
  13. 13

    Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation by Michael Marcy, S, Kohl, Katrin S, Dagan, Ron, Nalin, David, Blum, Michael, Jones, Marcy Connell, Hansen, John, Labadie, Jerry, Lee, Lucia, Martin, Bryan L, O’Brien, Katherine, Rothstein, Edward, Vermeer, Patricia

    Published in Vaccine (26-01-2004)
    “…Fever is endogenously generated and is distinguished from hyperthermia [1], which is a warming of the body caused by external environmental factors. Since…”
    Get full text
    Journal Article
  14. 14

    Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands by David, Silke, Vermeer-de Bondt, Patricia E, van der Maas, Nicoline A.T

    Published in Vaccine (29-10-2008)
    “…Abstract Background In addition to the routine enhanced passive safety surveillance of the Dutch National Vaccination Programme, RIVM (National Institute for…”
    Get full text
    Journal Article
  15. 15

    Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation by Bonhoeffer, Jan, Menkes, John, Gold, Michael S, de Souza-Brito, Glacus, Fisher, Margaret C, Halsey, Neal, Vermeer, Patricia

    Published in Vaccine (26-01-2004)
    “…The diagnosis of generalized convulsive seizure is based on descriptive terms for clinical signs and symptoms and does not require knowledge of ictal…”
    Get full text
    Journal Article
  16. 16

    Persistent crying in infants and children as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation by Bonhoeffer, Jan, Vermeer, Patricia, Halperin, Scott, Kempe, Anne, Music, Stanley, Shindman, Judy, Walop, Wikke

    Published in Vaccine (26-01-2004)
    “…[...]because the definition itself defines a clinical entity without inference of a causal relation to a given exposure, the time interval between immunization…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20